Obianuju Madueke-Laveaux to Uterine Neoplasms
This is a "connection" page, showing publications Obianuju Madueke-Laveaux has written about Uterine Neoplasms.
Connection Strength
2.054
-
Uterine Fibroid Prevalence in a Predominantly Black, Chicago-Based Cohort. Int J Environ Res Public Health. 2024 Feb 14; 21(2).
Score: 0.681
-
Fibroids and Fertility. Obstet Gynecol Clin North Am. 2023 Dec; 50(4):663-675.
Score: 0.664
-
Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies. Expert Opin Ther Targets. 2024 Aug; 28(8):669-687.
Score: 0.176
-
Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells. 2024 Jun 26; 13(13).
Score: 0.175
-
Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study. Am J Obstet Gynecol. 2024 02; 230(2):237.e1-237.e11.
Score: 0.166
-
GnRH agonists and antagonists in therapy of symptomatic uterine fibroids - current roles and future perspectives. Expert Opin Pharmacother. 2023 Sep-Dec; 24(16):1799-1809.
Score: 0.165
-
Evaluating ureteral patency in the post-indigo carmine era: a randomized controlled trial. Am J Obstet Gynecol. 2017 11; 217(5):601.e1-601.e10.
Score: 0.027